Your browser doesn't support javascript.
loading
Blood Hemoglobin Substantially Modulates the Impact of Gender, Morbid Obesity, and Hyperglycemia on COVID-19 Death Risk: A Multicenter Study in Italy and Spain.
Mayneris-Perxachs, Jordi; Russo, Maria Francesca; Ramos, Rafel; de Hollanda, Ana; Arxé, Arola Armengou; Rottoli, Matteo; Arnoriaga-Rodríguez, María; Comas-Cufí, Marc; Bartoletti, Michele; Verrastro, Ornella; Gudiol, Carlota; Fages, Ester; Giménez, Marga; Gil, Ariadna de Genover; Bernante, Paolo; Tinahones, Francisco; Carratalà, Jordi; Pagotto, Uberto; Hernández-Aguado, Ildefonso; Fernández-Aranda, Fernando; Meira, Fernanda; Castro Guardiola, Antoni; Mingrone, Geltrude; Fernández-Real, José Manuel.
Afiliação
  • Mayneris-Perxachs J; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona, Spain.
  • Russo MF; Nutrition, Eumetabolism and Health Group, Girona Biomedical Research Institute (IdibGi), Girona, Spain.
  • Ramos R; Department of Endocrinology and Nutrition, Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Madrid, Spain.
  • de Hollanda A; Fondazione Policlinico Universitario A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Università Cattolica del Sacro Cuore Rome, Rome, Italy.
  • Arxé AA; Department of Medical Sciences, School of Medicine, University of Girona, Girona, Spain.
  • Rottoli M; Vascular Health Research Group of Girona (ISV-Girona). Jordi Gol Institute for Primary Care Research (Institut Universitari per a la Recerca en AtencióPrimària Jordi Gol I Gurina -IDIAPJGol), Girona Biomedical Research Institute (IDIBGI), Dr. Josep Trueta University Hospital, Catalonia, Spain.
  • Arnoriaga-Rodríguez M; Girona Biomedical Research Institute (IDIBGI), Dr. Josep Trueta University Hospital, Catalonia, Spain.
  • Comas-Cufí M; Department of Endocrinology & Nutrition, Hospital Clínic Barcelona, Diabetes Unit, Barcelona, Spain.
  • Bartoletti M; Department of Endocrinology and Nutrition, Institut d'investigacions biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Verrastro O; Department of Internal Medicine, Service of Internal Medicine Dr. Josep Trueta University Hospital, Catalonia, Spain.
  • Gudiol C; Department of Surgery, Diabetology and Otolaryngology, Surgery of the Alimentary Tract and Centre for the Study and Research of Treatment for Morbid Obesity, Bologna, Italy.
  • Fages E; Infectious Diseases Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Sant'Orsola Policlinic, Bologna, Italy.
  • Giménez M; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona, Spain.
  • Gil AG; Nutrition, Eumetabolism and Health Group, Girona Biomedical Research Institute (IdibGi), Girona, Spain.
  • Bernante P; Department of Endocrinology and Nutrition, Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Madrid, Spain.
  • Tinahones F; Department of Medical Sciences, School of Medicine, University of Girona, Girona, Spain.
  • Carratalà J; Vascular Health Research Group of Girona (ISV-Girona). Jordi Gol Institute for Primary Care Research (Institut Universitari per a la Recerca en AtencióPrimària Jordi Gol I Gurina -IDIAPJGol), Girona Biomedical Research Institute (IDIBGI), Dr. Josep Trueta University Hospital, Catalonia, Spain.
  • Pagotto U; Infectious Diseases Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Sant'Orsola Policlinic, Bologna, Italy.
  • Hernández-Aguado I; Fondazione Policlinico Universitario A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Università Cattolica del Sacro Cuore Rome, Rome, Italy.
  • Fernández-Aranda F; Department of Infectious Diseases, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.
  • Meira F; Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain.
  • Castro Guardiola A; Spanish Network for Research in Infectious Disease (REIPI), Instituto de Salud Carlos III, Madrid, Spain.
  • Mingrone G; Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
  • Fernández-Real JM; Department of Oncology, Institut Català d'Oncologia (ICO) Hospitalet de Llobregat, Barcelona, Spain.
Front Endocrinol (Lausanne) ; 12: 741248, 2021.
Article em En | MEDLINE | ID: mdl-34795637
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Obesidade Mórbida / Hemoglobinas Glicadas / COVID-19 / Hiperglicemia Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Obesidade Mórbida / Hemoglobinas Glicadas / COVID-19 / Hiperglicemia Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha